Decimal assay for additivity of drugs permits delineation of synergy and antagonism.

AUTOR(ES)

Sanders, C C

RESUMO

Although there are many in vitro tests for drug interactions, few possess a linear, predictable dose-dependent end point or have a precise definition for additivity. Therefore, a new test with both of these features, the decimal assay for additivity, was developed. This test is based on a disk diffusion assay and the strict linear relationship between drug mass and size of the inhibition zone. When the decimal assay for additivity was applied to combinations known on a mechanistic basis to be additive, synergistic, or antagonistic, results of the new test always reflected the expected drug interaction. For example, synergy between trimethoprim and sulfamethoxazole was detected in tests with Escherichia coli and Haemophilus influenzae, as was antagonism between cefoxitin and cefotaxime in tests with Enterobacter cloacae. Quinolones plus chloramphenicol appeared to be antagonistic. In addition to correctly identifying the drug interaction, the decimal assay for additivity identified the drug ratio producing the maximal drug interaction. These results suggest that the decimal assay for additivity should prove very useful in future studies of drug interactions.

Documentos Relacionados

• Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro.
• Kava and dopamine antagonism.
• Heterodimerization of Msx and Dlx homeoproteins results in functional antagonism.
• Antiadrenergic effects of adenosine on His-Purkinje automaticity. Evidence for accentuated antagonism.
• Antibiotic Synergy and Antagonism Against Clinical Isolates of Klebsiella Species